ADA Scientific Sessions 2025 Abstract·13 JunEffect of Combined Therapy with Once-Weekly Subcutaneous Cagrilintide 2.4 mg and Semaglutide 2.4 mg (CagriSema) on Energy Intake, Gastric Emptying, and Appetite in Adults with Overweight or ObesityTrial in peopleInterventionsPaper